Financial News
Adial Pharmaceuticals Inc (NQ: ADIL )
2.380
USD
-0.040
(-1.65%)
Official Closing Price
Updated: 4:25 PM EDT, Apr 9, 2021
Add to My Watchlist
All news about Adial Pharmaceuticals Inc
From Benzinga
From Benzinga
Adial Receives $1.425 Million in Net Proceeds from Exercise of Warrants
February 26, 2021
Adial Pharmaceuticals Achieves 50% Enrollment in ONWARD™ Phase 3 Trial
February 25, 2021
48 Stocks Moving in Wednesday's Pre-Market Session
February 24, 2021
From Benzinga
Adial to File Fast Track Application for AD04 with the FDA
February 23, 2021
12 Health Care Stocks Moving In Monday's After-Market Session
February 22, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 22, 2021
From Benzinga
101 Biggest Movers From Friday
February 08, 2021
From Benzinga
From InvestorBrandNetwork
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 28, 2021
From Benzinga
Adial Pharmaceuticals Closes Acquisition of Purnovate
January 26, 2021
From ACCESSWIRE
Adial Pharmaceuticals to Present at 23rd Annual ICR Conference
January 11, 2021
From ACCESSWIRE
Adial Pharmaceuticals Receives Notice of Allowance for Third U.S. Patent Covering AD04 for the Treatment for Opioid Use Disorder
January 11, 2021
From ACCESSWIRE
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 04, 2021
From Benzinga
Adial Pharmaceuticals Appoints Dr. Jack Reich as Head of Regulatory
December 15, 2020
From ACCESSWIRE
Adial Pharmaceuticals Schedules Business Update Conference Call to Discuss Planned Acquisition of Purnovate and other Recent Developments
December 10, 2020
From ACCESSWIRE
Adial Pharmaceuticals Enters Agreement to Acquire Purnovate, a Developer of Potential Therapies for Non-Opioid Pain Reduction and Treatment of Addiction
December 10, 2020
From ACCESSWIRE
Adial Pharmaceuticals CEO Weighs in on the Alcohol Pandemic and Drunk Driving Over the Holidays; FOX31 Denver's Shaul Turner Interviews Bill Stilley
December 09, 2020
From ACCESSWIRE
From InvestorBrandNetwork
Adial Pharmaceuticals Lead Drug Candidate AD04 for Treatment of Alcohol Use Disorder Featured in Follow-up TV News Story
December 04, 2020
From ACCESSWIRE
12 Healthcare Stocks Moving In Wednesday's After-Market Session
December 02, 2020
From Benzinga
72 Biggest Movers From Yesterday
December 02, 2020
From Benzinga
52 Stocks Moving In Tuesday's Mid-Day Session
December 01, 2020
From Benzinga
45 Stocks Moving in Tuesday's Pre-Market Session
December 01, 2020
From Benzinga
What Are The Best Penny Stocks To Buy Right Now? 3 Under $3 To Watch
November 30, 2020
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
